Search

everythinglearnresearchcommunity

for

Search:↓

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Birth control pills are effective for treating women with too much male hormone.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.